Candidate bone-tissue-engineered product based on human-bone-derived cells and polyurethane scaffold.

Area of Science:

• Biomaterials Science
• Regenerative Medicine
• Orthopedic Engineering

Background:

• Biodegradable polyurethanes (PURs) show promise as biocompatible scaffolds for bone regenerative medicine.
• Previous studies indicate good in vivo biocompatibility and in vitro cell tolerance of certain PURs.
• Developing functional tissue-engineered products (TEPs) for bone regeneration requires robust cell-scaffold integration.

Purpose of the Study:

• To create and evaluate a tissue-engineered bone product using human osteogenic cells and a polyurethane scaffold.
• To assess the quality and in vivo performance of the developed TEP.
• To determine the suitability of the PUR scaffold and cell culture method for bone TEPs.

Main Methods:

• Human bone-derived cells (HBDCs) were seeded and cultured on PUR scaffolds in a bioreactor for 14 days.
• In vitro evaluation included cell number, phenotype, and distribution.
• TEPs were implanted subcutaneously in SCID mice for 4 and 13 weeks, followed by histological, immunohistochemical, and mechanical analyses.

Main Results:

• Dynamic bioreactor culture ensured homogeneous HBDC distribution, maintained proliferative potential, and preserved osteogenic phenotype.
• Implanted HBDCs survived and produced human bone extracellular matrix, leading to improved explant mechanical properties.
• The PUR scaffold system demonstrated successful integration and bone matrix formation in vivo.

Conclusions:

• The developed system, comprising a PUR scaffold and a dynamic human cell culture method, is a viable candidate for bone tissue-engineered products.
• This approach supports cell viability, osteogenic differentiation, and extracellular matrix deposition for enhanced bone regeneration.
• The study recommends this method for creating functional bone TEPs for regenerative medicine.